Toxins 2011, 3(3), 191-200; doi:10.3390/toxins3030191
Review

Monitoring Radiographic Brain Tumor Progression

Division of Neurosurgery, Duke University Medical Center, Box 3807, Durham, NC 27710, USA
* Author to whom correspondence should be addressed.
Received: 31 January 2011; in revised form: 3 February 2011 / Accepted: 11 March 2011 / Published: 15 March 2011
(This article belongs to the Special Issue Immunotoxins)
PDF Full-text Download PDF Full-Text [190 KB, uploaded 15 March 2011 10:58 CET]
Abstract: Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression.
Keywords: glioblastoma; radiographic progression; tumor progression; MRI

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Mehta, A.I.; Kanaly, C.W.; Friedman, A.H.; Bigner, D.D.; Sampson, J.H. Monitoring Radiographic Brain Tumor Progression. Toxins 2011, 3, 191-200.

AMA Style

Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH. Monitoring Radiographic Brain Tumor Progression. Toxins. 2011; 3(3):191-200.

Chicago/Turabian Style

Mehta, Ankit I.; Kanaly, Charles W.; Friedman, Allan H.; Bigner, Darell D.; Sampson, John H. 2011. "Monitoring Radiographic Brain Tumor Progression." Toxins 3, no. 3: 191-200.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert